Back
![](https://s3.ap-southeast-1.amazonaws.com/buckets.epicareer.com/employer/logo/20240412111417-270698-ix-biopharma.jpg)
iX Biopharma Ltd
Founded by : Eddy Lee, 1 January 2008
About the Company
iX Biopharma Ltd is a pharmaceutical company focusing on the development and commercialization of innovative therapies for pain management and CNS disorders. Their patented sublingual (under the tongue) drug delivery technology is designed to improve the bioavailability and efficacy of existing drugs, while reducing side effects. The company has a strong pipeline of products in various stages of development, including Wafermine, a sublingual fentanyl wafer for cancer pain management, and BNO1016, a sublingual ketamine spray for depression and other mood disorders. iX Biopharma is headquartered in Singapore and has operations in Australia, Europe, and the US. The company is publicly traded on the Australian Securities Exchange (ASX) under the ticker IXB.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, iX Biopharma Ltd’s industry classification falls within the following categories:
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Life Sciences Tools & Services
- Sub-Industry: Life Sciences Tools & Services
Videos and Photos
Company Address
1 Kim Seng Promenade, Great World City Office Tower, East Tower, #14-01 Singapore 237994
Source : Google maps